
Kauser M. Akhoon
Examiner (ID: 9457, Phone: (571)270-1026 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1613, 1642 |
| Total Applications | 267 |
| Issued Applications | 151 |
| Pending Applications | 2 |
| Abandoned Applications | 116 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9857342
[patent_doc_number] => 20150037360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'Lysosome-Cleavable Linker'
[patent_app_type] => utility
[patent_app_number] => 14/378138
[patent_app_country] => US
[patent_app_date] => 2013-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17362
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14378138
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/378138 | Lysosome-cleavable linker | Feb 4, 2013 | Issued |
Array
(
[id] => 13209089
[patent_doc_number] => 10118901
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => Therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 14/374995
[patent_app_country] => US
[patent_app_date] => 2013-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12340
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14374995
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/374995 | Therapeutic agents | Jan 30, 2013 | Issued |
Array
(
[id] => 9792308
[patent_doc_number] => 20150004253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'METHOD FOR THE PROGNOSIS OF SURVIVAL TIME OF A PATIENT SUFFERING FROM A SOLID CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/373246
[patent_app_country] => US
[patent_app_date] => 2013-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6875
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14373246
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/373246 | METHOD FOR THE PROGNOSIS OF SURVIVAL TIME OF A PATIENT SUFFERING FROM A SOLID CANCER | Jan 20, 2013 | Abandoned |
Array
(
[id] => 9545438
[patent_doc_number] => 20140170085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-19
[patent_title] => 'COSMETIC PREPARATION TAILORED TO THE INDIVIDUAL USER AND PROCESS FOR PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/745433
[patent_app_country] => US
[patent_app_date] => 2013-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3377
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13745433
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/745433 | COSMETIC PREPARATION TAILORED TO THE INDIVIDUAL USER AND PROCESS FOR PRODUCING SAME | Jan 17, 2013 | Abandoned |
Array
(
[id] => 9181249
[patent_doc_number] => 20130323234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-05
[patent_title] => 'MUTANT ANTIBODIES AND CONJUGATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/736029
[patent_app_country] => US
[patent_app_date] => 2013-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 87286
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13736029
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/736029 | MUTANT ANTIBODIES AND CONJUGATION THEREOF | Jan 6, 2013 | Abandoned |
Array
(
[id] => 8903576
[patent_doc_number] => 20130171079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'COMPOSITION TO STABILISE KOJIC ACID'
[patent_app_type] => utility
[patent_app_number] => 13/728973
[patent_app_country] => US
[patent_app_date] => 2012-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2376
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13728973
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/728973 | COMPOSITION TO STABILISE KOJIC ACID | Dec 26, 2012 | Abandoned |
Array
(
[id] => 10262353
[patent_doc_number] => 20150147350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'Method Of Treating Cancer With MEGEA3 Immunotherapeutic With BRAF Inhibitor And/Or MEK Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 14/364770
[patent_app_country] => US
[patent_app_date] => 2012-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13846
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14364770
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/364770 | Method Of Treating Cancer With MEGEA3 Immunotherapeutic With BRAF Inhibitor And/Or MEK Inhibitor | Dec 18, 2012 | Abandoned |
Array
(
[id] => 8866632
[patent_doc_number] => 20130150334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'TOPICAL FORMULATION FOR ADMINISTERING A COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 13/707264
[patent_app_country] => US
[patent_app_date] => 2012-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19706
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13707264
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/707264 | Topical formulation for administering a compound | Dec 5, 2012 | Issued |
Array
(
[id] => 10572999
[patent_doc_number] => 09295622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-29
[patent_title] => 'Substantive sunscreen formulation'
[patent_app_type] => utility
[patent_app_number] => 13/707134
[patent_app_country] => US
[patent_app_date] => 2012-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10674
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13707134
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/707134 | Substantive sunscreen formulation | Dec 5, 2012 | Issued |
Array
(
[id] => 9838507
[patent_doc_number] => 20150030588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'COMBINATION OF KINASE INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/357732
[patent_app_country] => US
[patent_app_date] => 2012-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 78052
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14357732
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/357732 | Combination of kinase inhibitors and uses thereof | Nov 11, 2012 | Issued |
Array
(
[id] => 12166054
[patent_doc_number] => 09884815
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-06
[patent_title] => 'PGAM1 inhibitors and methods related thereto'
[patent_app_type] => utility
[patent_app_number] => 14/349550
[patent_app_country] => US
[patent_app_date] => 2012-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 93
[patent_no_of_words] => 24296
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349550
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/349550 | PGAM1 inhibitors and methods related thereto | Oct 10, 2012 | Issued |
Array
(
[id] => 11723464
[patent_doc_number] => 09696313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-04
[patent_title] => 'HSF1 as a marker in tumor prognosis and treatment'
[patent_app_type] => utility
[patent_app_number] => 14/350328
[patent_app_country] => US
[patent_app_date] => 2012-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 38080
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350328
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350328 | HSF1 as a marker in tumor prognosis and treatment | Oct 4, 2012 | Issued |
Array
(
[id] => 9805784
[patent_doc_number] => 20150017728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'MONOMER ARCHITECTURE OF TAL NUCLEASE OR ZINC FINGER NUCLEASE FOR DNA MODIFICATION'
[patent_app_type] => utility
[patent_app_number] => 14/344526
[patent_app_country] => US
[patent_app_date] => 2012-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 24032
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344526
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/344526 | MONOMER ARCHITECTURE OF TAL NUCLEASE OR ZINC FINGER NUCLEASE FOR DNA MODIFICATION | Sep 18, 2012 | Abandoned |
Array
(
[id] => 9805210
[patent_doc_number] => 20150017156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'ESX-MEDIATED TRANSCRIPTION MODULATORS AND RELATED METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/344069
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20538
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344069
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/344069 | ESX-MEDIATED TRANSCRIPTION MODULATORS AND RELATED METHODS | Sep 13, 2012 | Abandoned |
Array
(
[id] => 9363739
[patent_doc_number] => 20140073612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'TRANSDERMAL DELIVERY SYSTEM KIT'
[patent_app_type] => utility
[patent_app_number] => 13/609810
[patent_app_country] => US
[patent_app_date] => 2012-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8901
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13609810
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/609810 | TRANSDERMAL DELIVERY SYSTEM KIT | Sep 10, 2012 | Abandoned |
Array
(
[id] => 9482494
[patent_doc_number] => 08728440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-20
[patent_title] => 'Nanoparticulate compositions for diagnostic imaging'
[patent_app_type] => utility
[patent_app_number] => 13/592853
[patent_app_country] => US
[patent_app_date] => 2012-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7868
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13592853
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/592853 | Nanoparticulate compositions for diagnostic imaging | Aug 22, 2012 | Issued |
Array
(
[id] => 9922271
[patent_doc_number] => 08980227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-17
[patent_title] => 'Dermal rejuvenation compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 13/587545
[patent_app_country] => US
[patent_app_date] => 2012-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8846
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13587545
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/587545 | Dermal rejuvenation compositions and methods | Aug 15, 2012 | Issued |
Array
(
[id] => 9643204
[patent_doc_number] => 20140221316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'NO- AND H2S- RELEASING COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/981378
[patent_app_country] => US
[patent_app_date] => 2012-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 25857
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13981378
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/981378 | No- and H2S-releasing compounds | Aug 14, 2012 | Issued |
Array
(
[id] => 11929789
[patent_doc_number] => 09796775
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Method for detecting pancreatic cancer'
[patent_app_type] => utility
[patent_app_number] => 14/236807
[patent_app_country] => US
[patent_app_date] => 2012-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20505
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236807
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/236807 | Method for detecting pancreatic cancer | Aug 2, 2012 | Issued |
Array
(
[id] => 8381499
[patent_doc_number] => 20120225122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'Abuse-Resistant Formulations'
[patent_app_type] => utility
[patent_app_number] => 13/470963
[patent_app_country] => US
[patent_app_date] => 2012-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22597
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470963
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/470963 | Abuse-Resistant Formulations | May 13, 2012 | Abandoned |